Copy Link Print Information

Tovecimig

(Synonyms: CTX-009)
Kundenbewertung

Based on 1 Customer Validation

HY-P991033 is an VEGFA/DLL4-targeting G1-scFvlh_L-κ type bispecific antibody.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 97.39%
  • CAS. Nr.: 2923284-73-3
  • Molecular Weight:199.624 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Tovecimig
  • Experimental Validation Results for Tovecimig
  • Experimental Validation Results for Tovecimig
  • Experimental Validation Results for Tovecimig
  • Tovecimig Chemical Structure
    Tovecimig Chemical Structure
CAS. Nr.: 2923284-73-3
Größe
Preis
Verfügbarkeit
Menge
Amount: USD 0.00
Please select quantity
or
or

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Tovecimig Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Finden Sie Ihren Händler vor Ort Your local distributor: Hycultec GmbHHycultec
  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Alle VEGFR Isoform-spezifische Produkte anzeigen

More
Keywords
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Einloggen
Registrieren
Sign in to MedChemExpress
Neuen Account Registrieren

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    IgG1-kappa-[scFv]2-lambda-heavy

  • 1/16

    Immobilized VEGF121 Protein, Human (120 a.a, HY-P7420) can bind Tovecimig. The EC50 for this effect is 10.9 ng/mL.

  • 1/16

    Immobilized Delta-like protein 4/DLL4 Protein, Human (HEK293, HY-P72972) can bind Tovecimig. The EC50 for this effect is 16.06 ng/mL.

  • 1/16

    Flow cytometric analysis of 1X106 HeLa cells with Tovecimig (HY-P991033, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control.

  • Tovecimig Chemical Structure
    1/16
  • Tovecimig
  • Immobilized VEGF121 Protein, Human (120 a.a, HY-P7420) can bind Tovecimig. The EC50 for this effect is 10.9 ng/mL.
  • Immobilized Delta-like protein 4/DLL4 Protein, Human (HEK293, HY-P72972) can bind Tovecimig. The EC50 for this effect is 16.06 ng/mL.
  • Flow cytometric analysis of 1X106 HeLa cells with Tovecimig (HY-P991033, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control.
  • IgG1-kappa-[scFv]2-lambda-heavy